FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2201163923> ?p ?o ?g. }

• W2201163923 endingPage "e0145772" @default.
• W2201163923 startingPage "e0145772" @default.
• W2201163923 abstract "The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and middle-income countries (LMICs) hardest hit by the HIV-1 pandemic. Genotypic drug resistance testing could facilitate the choice of initial ART in areas with rising transmitted drug resistance (TDR) and enable care-providers to determine which individuals with virological failure (VF) on a first- or second-line ART regimen require a change in treatment. An inexpensive near point-of-care (POC) genotypic resistance test would be useful in settings where the resources, capacity, and infrastructure to perform standard genotypic drug resistance testing are limited. Such a test would be particularly useful in conjunction with the POC HIV-1 viral load tests that are currently being introduced in LMICs. A POC genotypic resistance test is likely to involve the use of allele-specific point mutation assays for detecting drug-resistance mutations (DRMs). This study proposes that two major nucleoside reverse transcriptase inhibitor (NRTI)-associated DRMs (M184V and K65R) and four major NNRTI-associated DRMs (K103N, Y181C, G190A, and V106M) would be the most useful for POC genotypic resistance testing in LMIC settings. One or more of these six DRMs was present in 61.2% of analyzed virus sequences from ART-naïve individuals with intermediate or high-level TDR and 98.8% of analyzed virus sequences from individuals on a first-line NRTI/NNRTI-containing regimen with intermediate or high-level acquired drug resistance. The detection of one or more of these DRMs in an ART-naïve individual or in a individual with VF on a first-line NRTI/NNRTI-containing regimen may be considered an indication for a protease inhibitor (PI)-containing regimen or closer virological monitoring based on cost-effectiveness or country policy." @default.
• W2201163923 created "2016-06-24" @default.
• W2201163923 creator A5004821374 @default.
• W2201163923 creator A5005395265 @default.
• W2201163923 creator A5006120211 @default.
• W2201163923 creator A5009781874 @default.
• W2201163923 creator A5020377788 @default.
• W2201163923 creator A5020504018 @default.
• W2201163923 creator A5022691579 @default.
• W2201163923 creator A5024849121 @default.
• W2201163923 creator A5026793185 @default.
• W2201163923 creator A5027678141 @default.
• W2201163923 creator A5029038051 @default.
• W2201163923 creator A5029167470 @default.
• W2201163923 creator A5029881635 @default.
• W2201163923 creator A5031077871 @default.
• W2201163923 creator A5036869978 @default.
• W2201163923 creator A5042232387 @default.
• W2201163923 creator A5042521978 @default.
• W2201163923 creator A5048477426 @default.
• W2201163923 creator A5049494078 @default.
• W2201163923 creator A5052083685 @default.
• W2201163923 creator A5054490440 @default.
• W2201163923 creator A5055530120 @default.
• W2201163923 creator A5058930906 @default.
• W2201163923 creator A5061720638 @default.
• W2201163923 creator A5066628402 @default.
• W2201163923 creator A5073322790 @default.
• W2201163923 creator A5077500073 @default.
• W2201163923 creator A5078478462 @default.
• W2201163923 creator A5078706099 @default.
• W2201163923 creator A5080859236 @default.
• W2201163923 creator A5088720312 @default.
• W2201163923 creator A5089971063 @default.
• W2201163923 date "2015-12-30" @default.
• W2201163923 modified "2023-09-29" @default.
• W2201163923 title "HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing" @default.
• W2201163923 cites W1967760407 @default.
• W2201163923 cites W1967857516 @default.
• W2201163923 cites W1977136326 @default.
• W2201163923 cites W1981443783 @default.
• W2201163923 cites W1984820496 @default.
• W2201163923 cites W1987278538 @default.
• W2201163923 cites W1997141231 @default.
• W2201163923 cites W2004345778 @default.
• W2201163923 cites W2004850385 @default.
• W2201163923 cites W2011518212 @default.
• W2201163923 cites W2020533061 @default.
• W2201163923 cites W2036408211 @default.
• W2201163923 cites W2043375510 @default.
• W2201163923 cites W2045871034 @default.
• W2201163923 cites W2073030868 @default.
• W2201163923 cites W2084302660 @default.
• W2201163923 cites W2097457247 @default.
• W2201163923 cites W2098714511 @default.
• W2201163923 cites W2106026141 @default.
• W2201163923 cites W2107737729 @default.
• W2201163923 cites W2112763551 @default.
• W2201163923 cites W2114872199 @default.
• W2201163923 cites W2116365203 @default.
• W2201163923 cites W2120293408 @default.
• W2201163923 cites W2120637537 @default.
• W2201163923 cites W2121717451 @default.
• W2201163923 cites W2129186628 @default.
• W2201163923 cites W2131295062 @default.
• W2201163923 cites W2140227530 @default.
• W2201163923 cites W2141304944 @default.
• W2201163923 cites W2142118082 @default.
• W2201163923 cites W2143326808 @default.
• W2201163923 cites W2149062343 @default.
• W2201163923 cites W2152896082 @default.
• W2201163923 cites W2153370925 @default.
• W2201163923 cites W2159343812 @default.
• W2201163923 cites W2163914644 @default.
• W2201163923 cites W2168797913 @default.
• W2201163923 cites W2170463669 @default.
• W2201163923 cites W2171236519 @default.
• W2201163923 cites W2289938826 @default.
• W2201163923 cites W2308294549 @default.
• W2201163923 cites W2323185049 @default.
• W2201163923 cites W2333158910 @default.
• W2201163923 doi "https://doi.org/10.1371/journal.pone.0145772" @default.
• W2201163923 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4696791" @default.
• W2201163923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26717411" @default.
• W2201163923 hasPublicationYear "2015" @default.
• W2201163923 type Work @default.
• W2201163923 sameAs 2201163923 @default.
• W2201163923 citedByCount "67" @default.
• W2201163923 countsByYear W22011639232016 @default.
• W2201163923 countsByYear W22011639232017 @default.
• W2201163923 countsByYear W22011639232018 @default.
• W2201163923 countsByYear W22011639232019 @default.
• W2201163923 countsByYear W22011639232020 @default.
• W2201163923 countsByYear W22011639232021 @default.
• W2201163923 countsByYear W22011639232022 @default.
• W2201163923 countsByYear W22011639232023 @default.
• W2201163923 crossrefType "journal-article" @default.
• W2201163923 hasAuthorship W2201163923A5004821374 @default.

• next